Dotter
Medical device company focused on diagnosis and treatment of ischemic heart disease. Develops intravascular optical coherence tomography (OCT) imaging systems and catheters, designs and manufactures bioresorbable coronary stents and related interventional devices, and develops AI-based software for intraprocedural image analysis. Operates GMP sites in Korea and participates in clinical trials and device commercialization.
Industries
Nr. of Employees
small (1-50)
Dotter
Headquarter A-911, 323 Incheon Tower-Daero, Yeonsu-Gu, Incheon 22007, Korea
Patents
Deep learning based image segmentation method including biodegradable stent in intravascular optical tomography image
US-11972574-B2
View Details
Deep learning based image segmentation method including biodegradable stent in intravascular optical tomography image
US-11972574-B2
View DetailsProducts
Bioresorbable coronary scaffold (BRS)
Third-generation fully bioresorbable coronary scaffold designed with V-shaped thin struts and MPC surface coating for drug release; strut thickness ~100 µm and intended to resorb in ~3 years.
Intravascular OCT imaging system (Aurios S100)
High-resolution intravascular OCT console designed for lesion observation during PCI, providing higher axial resolution than conventional intravascular imaging and integration with software analysis tools.
OCT imaging catheter (Benetis)
Optical-fiber catheter optimized for intravascular OCT imaging with torque stability, radiopaque markers and compatibility with standard 0.014" guidewires.
PTCA balloon catheter (Venavis)
Non-compliant and semi-compliant percutaneous coronary balloon catheters with tapered tips, coated shafts, and radiopaque markers for improved lesion crossing and visibility.
Commercially sourced drug-eluting stent (domestic distribution)
Domestic distribution and marketing of a ridaforolimus-eluting cobalt-chromium stent system under license from an external developer.
Bioresorbable coronary scaffold (BRS)
Third-generation fully bioresorbable coronary scaffold designed with V-shaped thin struts and MPC surface coating for drug release; strut thickness ~100 µm and intended to resorb in ~3 years.
Intravascular OCT imaging system (Aurios S100)
High-resolution intravascular OCT console designed for lesion observation during PCI, providing higher axial resolution than conventional intravascular imaging and integration with software analysis tools.
OCT imaging catheter (Benetis)
Optical-fiber catheter optimized for intravascular OCT imaging with torque stability, radiopaque markers and compatibility with standard 0.014" guidewires.
PTCA balloon catheter (Venavis)
Non-compliant and semi-compliant percutaneous coronary balloon catheters with tapered tips, coated shafts, and radiopaque markers for improved lesion crossing and visibility.
Commercially sourced drug-eluting stent (domestic distribution)
Domestic distribution and marketing of a ridaforolimus-eluting cobalt-chromium stent system under license from an external developer.
Services
Real-time software for morphological measurements, automated lumen and stenosis assessment, 3D visualization, and stenting assistance during coronary interventions.
Support for clinical trial execution including patient enrollment and device evaluation in hospital settings.
Market authorization, labeling, and distribution of coronary stent systems and related interventional devices within Korea.
Real-time software for morphological measurements, automated lumen and stenosis assessment, 3D visualization, and stenting assistance during coronary interventions.
Support for clinical trial execution including patient enrollment and device evaluation in hospital settings.
Market authorization, labeling, and distribution of coronary stent systems and related interventional devices within Korea.
Expertise Areas
- Cardiovascular device development
- Intravascular imaging
- Bioresorbable scaffold engineering
- Interventional cardiology device manufacturing
Key Technologies
- Optical coherence tomography (OCT)
- Fluorescence lifetime imaging (FLIm)
- Intravascular optical-fiber catheters
- AI / neural-network image analysis
News & Updates
Domestic regulatory approval (MFDS) granted for an intravascular OCT imaging catheter model.
Domestic approval obtained for a multimodal FLIm-OCT intravascular imaging technology.
Clinical recruitment completed for a bioresorbable stent (128 patients enrolled) as part of ongoing clinical development.
Acquisition of exclusive domestic rights to market a ridaforolimus-eluting stent system in Korea.
Domestic regulatory approval (MFDS) granted for an intravascular OCT imaging catheter model.
Domestic approval obtained for a multimodal FLIm-OCT intravascular imaging technology.
Clinical recruitment completed for a bioresorbable stent (128 patients enrolled) as part of ongoing clinical development.
Acquisition of exclusive domestic rights to market a ridaforolimus-eluting stent system in Korea.